Irbesartan And Hydrochlorothiazide Tablet
Product Images NDC 71335-1787

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 71335-1787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1a.jpg (Figure1a)

A line graph showing the percentage of subjects with systolic blood pressure (SBP) less than 140 mmHg plotted against baseline SBP in mmHg. The graph includes multiple study groups related to Irbesartan and Hydrochlorothiazide: Irb.-HCTZ Study V, Irb. Study V, HCTZ Study V, Irb.-HCTZ Study VI, and Irb. Study VI, each represented by different line styles as indicated in the legend.*

FDA Label Image

Figure1b.jpg (Figure1b)

A line graph depicting the percentage of subjects with systolic blood pressure (SBP) less than 130 mmHg versus baseline SBP (mmHg). The graph includes multiple lines representing different studies and treatments: Irbesartan-Hydrochlorothiazide Study V, Irbesartan Study V, Hydrochlorothiazide Study V, Irbesartan-Hydrochlorothiazide Study VI, and Irbesartan Study VI, each differentiated by line style and thickness.*

FDA Label Image

Figure2a.jpg (Figure2a)

This chart depicts the percentage of patients achieving a diastolic blood pressure (DBP) under 90 mmHg plotted against baseline DBP in mmHg. It includes multiple studies represented by different line styles: Irbesartan-Hydrochlorothiazide (Irb.-HCTZ) Study V and VI, Irbesartan Study V and VI, and Hydrochlorothiazide (HCTZ) Study V, comparing the efficacy of the drug components.*

FDA Label Image

Figure2b.jpg (Figure2b)

A line graph depicting the percentage of diastolic blood pressure (DBP) readings below 80 mmHg plotted against baseline DBP (mmHg). The graph includes multiple study lines comparing Irbesartan and Hydrochlorothiazide (Irb.-HCTZ) combinations and individual components from Studies V and VI. The legend differentiates the data by line style for each treatment and study.*

FDA Label Image

Figure3.jpg (Figure3)

A scatter plot with a fitted curve showing data points representing mmHg values on the vertical axis versus Irbesartan Dose (mg/day) on the horizontal axis, illustrating a relationship trend between these variables.*

FDA Label Image

Figure4.jpg (Figure4)

A scatter plot with a fitted curve illustrating the relationship between Irbesartan Dose (mg/day) on the x-axis and a measured response in mmHg on the y-axis. The data points show variability, with the response increasing and leveling off as the dose increases up to about 900 mg/day.*

FDA Label Image

Hydrochlorothiazide.jpg (Hydrochlorothiazide)

Chemical structure illustration showing the molecular structure of Hydrochlorothiazide, an active ingredient in Irbesartan and Hydrochlorothiazide tablets. The diagram includes atoms such as sulfur, oxygen, nitrogen, chlorine, and carbon arranged in a specific chemical configuration.*

FDA Label Image

Label (Lbl713351787)

Label for Irbesartan and Hydrochlorothiazide Tablets, USP 150 mg/12.5 mg by Bryant Ranch Prepack, with a quantity of 30 tablets. Includes NDC 63629-7468-01, storage instructions, and a BRP Pharmaceuticals logo.*

FDA Label Image

Lbl7133517872

Label for Irbesartan Hctz 150/12.5 mg tablet by Bryant Ranch Prepack. The label compares the product to Avalid 150/12.5 mg tablet by West-Ward Columbus Inc. It includes storage instructions to keep at 20°-25°C (68°-77°F) and to keep all drugs out of reach of children. The package contains 30 tablets and includes the NDC number 71335-1787-1.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram showing the molecular structure of Irbesartan, part of the combination drug Irbesartan and Hydrochlorothiazide. The structure includes rings and chains representing the chemical groups present in the Irbesartan molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.